About Radical Prostatectomy (RP)
Patients randomized to radical prostatectomy arm will receive radical prostatectomy performed as per standard clinical practice at your site, with no restriction on approach. Radical Prostatectomy is a procedure that involves the surgical removal of the prostate and some tissue around it. For men with localized, intermediate-risk prostate cancer, RP is recommended in the national guidelines to be a standard-of-care treatment and has been proven in large randomized controlled trials to reduce the long-term risk of dying from prostate cancer.
About the TULSA Procedure
The Transurethral Ultrasound Ablation (TULSA) Procedure uses directional thermal ultrasound to ablate diseased prostate tissue. It has been demonstrated to be effective at ablating prostate tissue in men with localized, intermediate-risk prostate cancer. The TULSA Procedure is performed in a Magnetic Resonance Imaging (MRI) suite and uses the TULSA-PRO® system to ablate prostate tissue from the ‘inside-out’ (from inside the urethra heating outwards to the edge of the prostate). The TULSA Procedure is cleared for use by the United States Food and Drug Administration (FDA), and Health Canada.